YCS21· AIParallel Bio
Using the immune system to cure disease
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
SFA TherapeuticsS21Regulating the immune system to block cancer & autoimmune diseasesShared: ai-powered drug discovery, biotechActive
Harmonic DiscoveryS21Multi-targeted therapeutics to treat complex diseasesShared: ai-powered drug discovery, biotechActive
Output BiosciencesS21The foundation for the next era of biologyShared: ai-powered drug discovery, biotechActive
Rosebud BiosciencesW22Growing micro-organs to find new drugsShared: ai-powered drug discovery, biotechActive
Numerion LabsW15Artificial intelligence for drug discovery.Shared: ai-powered drug discovery, biotechActive
Adjacent
Overlapping tags, a different niche.
Lavo Life SciencesW23AI for drug formulationShared: ai-powered drug discovery, biotechInactive
Tamarind BioW24AI Inference Platform for Drug DiscoveryShared: ai-powered drug discovery, biotechActive
ConvexiaS25The world's first AI-maximalist pharma companyShared: ai-powered drug discovery, biotechActive
NanograbS23Deliver genes to any cell with AIShared: ai-powered drug discovery, biotechActive
Synkrino BiotherapeuticsS18Synkrino's AI, SATIS is a powerful, unbiased discovery system for…Shared: ai-powered drug discovery, biotechActive
Also from S21 in AI
Batchmates in Summer 2021.
AdaptyvS21We're building fully automated labs for protein engineeringActive
CellChorusS21The dynamic single-cell analysis companyActive
MatrubialsS21Developing milk-inspired therapeutics for infectious diseasesActive
Medium BiosciencesS21AI-designed Affinity ReagentsActive
Mindstate Design LabsS21Programmable biology company for psychoactive effect designActive
AbstraS21Automate finance operations with Python and AIActive
About Parallel Bio
Parallel Bio is pioneering human-first drug discovery by creating the first map of human biology. Using groundbreaking biological and computational tools that track real clinical outcomes, the company generates data that enable earlier, more reliable decisions about disease biology and drug development. Parallel Bio’s platform overcomes the core limitations of traditional animal testing, which fails to encapsulate the complexity of human biology. The company is building internal pipelines of novel disease targets and drug candidates in both cancer and autoimmune disease, while collaborating with pharmaceutical companies to evaluate therapies directly in human systems to reduce the cost and risk of clinical trials. Based in San Francisco, the company was founded in 2021 by two of the world’s leading experts in replacing animal models with human-first platforms.
San Francisco, CA, USA
Parallel Bio: questions
Which YC batch was Parallel Bio in?
Parallel Bio was in Y Combinator's Summer 2021 batch (S21).
Is Parallel Bio still active?
Y Combinator lists Parallel Bio as active.
Where is Parallel Bio based?
Parallel Bio lists San Francisco, CA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.